| Oxaliplatin-induced lung fibrosis. | |
| | |
MedLine Citation:
|
PMID: 20838550 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Oxaliplatin has been approved for use as an adjuvant treatment in stage III colorectal carcinoma by the US-FDA. The majority of toxicity caused by this drug is manageable. However, rare, isolated cases of pulmonary fibrosis induced by this drug have been reported in literature. We report one such case of rapidly evolving pulmonary fibrosis following treatment with oxaliplatin. |
| | |
Authors:
|
Arpan Shah; Zarir F Udwadia; Sachin Almel |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology Volume: 30 ISSN: 0975-2129 ISO Abbreviation: Indian J Med Paediatr Oncol Publication Date: 2009 Jul |
Date Detail:
|
Created Date: 2010-09-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9604571 Medline TA: Indian J Med Paediatr Oncol Country: India |
Other Details:
|
Languages: eng Pagination: 116-8 Citation Subset: - |
Affiliation:
|
Departments of Chest Medicine, P.D. Hinduja Hospital, Veer Savarkar Marg, Mahim (W), Mumbai, India. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Uterine C-Kit positive low grade stromal sarcoma.
Next Document: Metastatic squamous cell carcinoma neck with occult primary: A retrospective analysis.